243 related articles for article (PubMed ID: 32532289)
41. "Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction".
Papaccio F; García-Mico B; Gimeno-Valiente F; Cabeza-Segura M; Gambardella V; Gutiérrez-Bravo MF; Alfaro-Cervelló C; Martinez-Ciarpaglini C; Rentero-Garrido P; Zúñiga-Trejos S; Carbonell-Asins JA; Fleitas T; Roselló S; Huerta M; Sánchez Del Pino MM; Sabater L; Roda D; Tarazona N; Cervantes A; Castillo J
J Exp Clin Cancer Res; 2023 Jan; 42(1):8. PubMed ID: 36604765
[TBL] [Abstract][Full Text] [Related]
42. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
[TBL] [Abstract][Full Text] [Related]
43. Advances in the use of 3D colorectal cancer models for novel drug discovery.
Baião A; Dias S; Soares AF; Pereira CL; Oliveira C; Sarmento B
Expert Opin Drug Discov; 2022 Jun; 17(6):569-580. PubMed ID: 35343351
[TBL] [Abstract][Full Text] [Related]
44. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
45. Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challenges.
Durinikova E; Buzo K; Arena S
J Exp Clin Cancer Res; 2021 Jun; 40(1):185. PubMed ID: 34090508
[TBL] [Abstract][Full Text] [Related]
46. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases.
Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM
Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907
[TBL] [Abstract][Full Text] [Related]
47. The adaptation of colorectal cancer cells when forming metastases in the liver: expression of associated genes and pathways in a mouse model.
Bocuk D; Wolff A; Krause P; Salinas G; Bleckmann A; Hackl C; Beissbarth T; Koenig S
BMC Cancer; 2017 May; 17(1):342. PubMed ID: 28525976
[TBL] [Abstract][Full Text] [Related]
48. Human liver organoids for disease modeling of fibrolamellar carcinoma.
Narayan NJC; Requena D; Lalazar G; Ramos-Espiritu L; Ng D; Levin S; Shebl B; Wang R; Hammond WJ; Saltsman JA; Gehart H; Torbenson MS; Clevers H; LaQuaglia MP; Simon SM
Stem Cell Reports; 2022 Aug; 17(8):1874-1888. PubMed ID: 35803261
[TBL] [Abstract][Full Text] [Related]
49. Evidence of heterogeneity within colorectal liver metastases for allelic losses, mRNA level expression and in vitro response to chemotherapeutic agents.
Goasguen N; de Chaisemartin C; Brouquet A; Julié C; Prevost GP; Laurent-Puig P; Penna C
Int J Cancer; 2010 Sep; 127(5):1028-37. PubMed ID: 20017140
[TBL] [Abstract][Full Text] [Related]
50. Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data.
Tbeileh N; Timmerman L; Mattis AN; Toriguchi K; Kasai Y; Corvera C; Nakakura E; Hirose K; Donner DB; Warren RS; Karelehto E
PLoS One; 2023; 18(4):e0271354. PubMed ID: 37022995
[TBL] [Abstract][Full Text] [Related]
51. Modeling colorectal cancer: A bio-resource of 50 patient-derived organoid lines.
Engel RM; Jardé T; Oliva K; Kerr G; Chan WH; Hlavca S; Nickless D; Archer SK; Yap R; Ranchod P; Bell S; Niap A; Koulis C; Chong A; Wilkins S; Dale TC; Hollins AJ; McMurrick PJ; Abud HE
J Gastroenterol Hepatol; 2022 May; 37(5):898-907. PubMed ID: 35244298
[TBL] [Abstract][Full Text] [Related]
52. Living donor liver transplantation with two-stage hepatectomy for patients with isolated, irresectable colorectal liver-the LIVER-T(W)O-HEAL study.
Rauchfuß F; Nadalin S; Königsrainer A; Settmacher U
World J Surg Oncol; 2019 Jan; 17(1):11. PubMed ID: 30621712
[TBL] [Abstract][Full Text] [Related]
53. The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers.
Orjuela S; Menigatti M; Schraml P; Kambakamba P; Robinson MD; Marra G
BMC Cancer; 2020 Apr; 20(1):290. PubMed ID: 32252665
[TBL] [Abstract][Full Text] [Related]
54. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
[TBL] [Abstract][Full Text] [Related]
55. Modeling Colorectal Cancer Progression Through Orthotopic Implantation of Organoids.
de Sousa E Melo F; Harnoss JM; Kljavin N; Scott R; Sohn C; Leong KG; de Sauvage FJ
Methods Mol Biol; 2020; 2171():331-346. PubMed ID: 32705654
[TBL] [Abstract][Full Text] [Related]
56. Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
Sabanathan D; Eslick GD; Shannon J
Clin Colorectal Cancer; 2016 Dec; 15(4):e141-e147. PubMed ID: 27174607
[TBL] [Abstract][Full Text] [Related]
57. The role of biological agents in the resection of colorectal liver metastases.
Nordlinger B; Adam R; Arnold D; Zalcberg JR; Gruenberger T
Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):432-42. PubMed ID: 22794325
[TBL] [Abstract][Full Text] [Related]
58. Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity.
Brown KM; Xue A; Julovi SM; Gill AJ; Pavlakis N; Samra JS; Smith RC; Hugh TJ
J Surg Res; 2018 Jul; 227():158-167. PubMed ID: 29804848
[TBL] [Abstract][Full Text] [Related]
59. Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer Discovery.
Kim YS; Hsieh AC; Lam HM
Eur Urol Focus; 2022 May; 8(3):657-659. PubMed ID: 35915037
[TBL] [Abstract][Full Text] [Related]
60. Impact of Single-organ Metastasis to the Liver or Lung and Genetic Mutation Status on Prognosis in Stage IV Colorectal Cancer.
Cavallaro P; Bordeianou L; Stafford C; Clark J; Berger D; Cusack J; Kunitake H; Francone T; Ricciardi R
Clin Colorectal Cancer; 2020 Mar; 19(1):e8-e17. PubMed ID: 31899147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
